DAVID BATES to Protein Kinase Inhibitors
This is a "connection" page, showing publications DAVID BATES has written about Protein Kinase Inhibitors.
Connection Strength
0.800
-
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular disease. Am J Physiol Heart Circ Physiol. 2025 Aug 01; 329(2):H490-H504.
Score: 0.678
-
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells. Cancer Res Treat. 2021 Apr; 53(2):457-470.
Score: 0.122